Coave Therapeutics to Present at Upcoming Conferences

Coave Therapeutics to Present at Upcoming Conferences

Paris, France, March 27, 2024 – Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies, announces that its management will be attending the following upcoming investor and industry conferences:

• Cell & Gene Meeting on the Med – April 9-11 ; Rome, Italy

Company Presentation by CEO Rodolphe Clerval on April 10 at 13.45 CET

• LSX World Congress – April 29-30 ; London, UK

CEO Rodolphe Clerval attending and available for investor meetings

• BioEquity Europe – May 12-24 ; San Sebastián, Spain

Company Presentation by CEO Rodolphe Clerval - Date/Time TBC

• Gene Therapy Analytical Development Europe Summit - May 22-24 ; London, UK

Presentation by COO Patricia Françon on May 24 at 10.00 BST

In addition, Coave’s scientific team will be present at the upcoming scientific, medical & regulatory conferences:

• ARVO (Association for Research in Vision and Ophthalmology) - May 5-6 ; Seattle, WA, US

• ASGCT (American Society of Gene and Cell Therapy) - May 7-11 ; Baltimore, MD, US